News | Mammography | April 13, 2016

Keynote delivered by Nancy M. Cappello, executive director and founder of breast density inform advocacy groups

Fujifilm, NCoBC 2016, keynote presentation, Nancy Cappello, Aspire Cristalle mammography system

April 13, 2016 — Fujifilm Medical Systems U.S.A. Inc. sponsored the keynote presentation at the National Consortium of Breast Centers (NCoBC) 2016 conference delivered by Nancy M. Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy Inc. Fujifilm also showcased its Aspire Cristalle mammography system at the conference, April 9-13 in Las Vegas.

Cappello’s keynote remarks —“Why I Talk to Strangers About My Breasts”— focused on fibroglandular breast density ramifications and legislation. The impact of dense breast tissue remained exclusively in the medical journals for more than a decade until, in 2009, through Cappello’s activism, Connecticut, her home state, became the first state to mandate the reporting of dense breast tissue to the patient through the mammography report.

Cappello then launched Are You Dense Inc. and Are You Dense Advocacy Inc., both working together as a global grassroots density education and reporting movement.

“It is my personal priority—and the mission of my organizations— to ensure that patients, policymakers and healthcare providers understand the significance of dense breast tissue and the importance of regular, reliable screening,” said Cappello. “I am very grateful to have the support of Fujifilm, a company that clearly understands how educational efforts and awareness-building can help save lives.”

Fujifilm’s Aspire Cristalle mammography system features an innovative hexagonal close pattern (HCP) detector design, engineered for higher acquisition efficiency, to enhance detail for improved low dose performance. The result is sharper images with gentler dose to the patient. Additionally, Aspire Cristalle incorporates a patient calming design and Fujifilm’s patented Comfort Paddle, which is designed to make the most physically unpleasant part of mammograms noticeably more comfortable for the patient.

For more information: www.fujifilmhealthcare.com


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
Subscribe Now